Moreover, other cancer cell lines should be tested for their guanosine sensitivity, and the data should be correlated with expression levels of ENT1 (e.g. as determined by [3H]NBMPR binding) or with the guanosine uptake capacity (e.g. uptake of [3H]guanosine). This evidence concerns the gene SLC29A1 and cancer.